New Zealand markets close in 5 hours 54 minutes

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
271.12+1.18 (+0.44%)
At close: 4:00PM EDT
271.00 -0.12 (-0.04%)
After hours: 05:35PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 538.90B
Enterprise value 343.56B
Trailing P/E 25.34
Forward P/E 113.74
PEG ratio (5-yr expected) 16.24
Price/sales (ttm)3.61
Price/book (mrq)3.73
Enterprise value/revenue 33.92
Enterprise value/EBITDA 714.53

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 35.73%
S&P500 52-week change 334.68%
52-week high 3468.55
52-week low 3223.25
50-day moving average 3288.10
200-day moving average 3312.44

Share statistics

Avg vol (3-month) 3983.8k
Avg vol (10-day) 31.47M
Shares outstanding 5146.89M
Implied shares outstanding 6N/A
Float 8148.63M
% held by insiders 10.68%
% held by institutions 188.01%
Shares short (29 Sep 2021) 42.49M
Short ratio (29 Sep 2021) 42.35
Short % of float (29 Sep 2021) 41.88%
Short % of shares outstanding (29 Sep 2021) 41.67%
Shares short (prior month 30 Aug 2021) 42.38M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 317 Jan 2001

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Jun 2021

Profitability

Profit margin 16.40%
Operating margin (ttm)24.03%

Management effectiveness

Return on assets (ttm)7.03%
Return on equity (ttm)22.14%

Income statement

Revenue (ttm)11.7B
Revenue per share (ttm)76.48
Quarterly revenue growth (yoy)-24.60%
Gross profit (ttm)11.64B
EBITDA 3.25B
Net income avi to common (ttm)1.92B
Diluted EPS (ttm)12.50
Quarterly earnings growth (yoy)-70.90%

Balance sheet

Total cash (mrq)3.05B
Total cash per share (mrq)20.47
Total debt (mrq)7.63B
Total debt/equity (mrq)68.06
Current ratio (mrq)2.15
Book value per share (mrq)72.11

Cash flow statement

Operating cash flow (ttm)2.81B
Levered free cash flow (ttm)1.86B